Our findings support the concept that tMSLCs potentiate GBM malignancy via autocrine and paracrine mechanisms17,38, including the secretion of C5a and other cytokines, thereby presenting a critical therapeutic axis to counteract the malignancy exacerbated by tMSLCs30,31,39. Here, C5 is linked to glioblastoma.